Project Grant HT94252510927
Award Date 9/30/25
Completion Date 9/29/29
Dollars Obligated $715K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
White River Junction, VT 05009, USA
Similar Awards
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,508,132.00 in funding to the University of Rhode Island (URI) to conduct research on the use of bile acid-binding resins to decrease systemic per- and polyfluoroalkyl substance (PFAS) levels and improve serum lipid profiles in veterans. The award period runs from September 30, 2025 to September 29, 2029. The research aims to develop innovative medical...
- This federal Project Grant award of $1,293,748.00, made by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research to investigate the use of bile acid-binding resins to decrease systemic per- and polyfluoroalkyl substance (PFAS) levels and improve serum lipid profiles in veterans. The research will be conducted by the University of Louisville's Office of Research & Innovation over a performance period from September 30, 2025 to...
- The Defense Health Agency awarded a $1,117,352 Project Grant to Trustees of Boston University's Boston University Medical Campus to develop a novel and practical intervention for detoxification of per- and polyfluoroalkyl substances (PFAS) in humans. The grant, funded under the Military Medical Research and Development program (CFDA 12.420), supports the university's research to transform health care for Service Members and the public through innovative biomedical research. As part of the...
- The U.S. Defense Health Agency awarded a $2,916,605 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the Boston VA Research Institute, Inc. (BVARI) on September 30, 2023. The 4-year award, titled "LONG-TERM PSYCHOLOGICAL AND PHYSICAL HEALTH OUTCOMES FOLLOWING MILITARY DEPLOYMENT: THE VETERANS AFTER-DISCHARGE LONGITUDINAL REGISTRY (PROJECT VALOR)", will fund BVARI's research to investigate risk factors, prevention, and...
- This $864,533 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Metis Foundation, a non-profit organization based in San Antonio, Texas. The purpose of this 3-year award, with a performance period from September 30, 2025 to September 29, 2028, is to conduct research on the association between PFAS and other toxic military exposures and pancreatic cancer risk in a military population. The Metis Foundation, which...
- This Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $284,000.00 to the Palo Alto Veterans Institute For Research (PAVIR) to conduct research on novel Fc receptor blockers as potential disease-modifying analgesics. The research will take place from July 1, 2024 to June 30, 2026. PAVIR is a non-profit organization closely affiliated with the VA and Stanford University that has a long history of securing federal grants and...
- This federal Project Grant award of $660,283.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by Carnegie Mellon University to develop a high-throughput bioanalytical and machine learning approach for prioritizing bioaccumulative per- and polyfluoroalkyl substances (PFAS) in complex mixtures. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing...
- The Veterans Medical Research Foundation of San Diego was awarded a $4,802,696 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2025, supports a four-year research project titled "A HYBRID I EVALUATION OF INTEGRATIVE HEALTH CARE FOR PTSD". The research aims to transform healthcare for military service members, veterans, and the broader public by conducting advanced biomedical...
- The Defense Health Agency awarded a $614,140 Project Grant to the Portland VA Research Foundation, Inc. to conduct research on polygenic risk scores (PRS) to predict post-traumatic epilepsy (PTE) in the Million Veteran Program (MVP) cohort. This research falls under the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The award period runs from July 1, 2025,...
- The federal Project Grant award of $923,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by the Palo Alto Veterans Institute for Research (PAVIR) to engage veterans with lung cancer. The award, with a performance period from August 1, 2025 to July 31, 2028, will fund PAVIR's research initiatives focused on transforming healthcare for military service members, veterans, and the broader public. As a non-profit research...